Contemporary medicinal chemistry strategies for the discovery and development of novel HIV-1 non-nucleoside reverse transcriptase inhibitors

Z Wang, S Cherukupalli, M Xie, W Wang… - Journal of Medicinal …, 2022 - ACS Publications
Currently, HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) are a major
component of the highly active anti-retroviral therapy (HAART) regimen. However, the …
被引用次数：37 相关文章
[PDF] kuleuven.be

[PDF][PDF] Contemporary medicinal chemistry strategies for the discovery and development of novel HIV-1 nonnucleoside reverse transcriptase inhibitors

Z Wanga, S Cherukupallia, M Xiea, W Wanga, X Jianga… - lirias.kuleuven.be
Currently, HIV-1 nonnucleoside reverse transcriptase inhibitors (NNRTIs) are a major
component of the highly active antiretroviral therapy (HAART) regimen. However, the …

Contemporary Medicinal Chemistry Strategies for the Discovery and Development of Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors

Z Wang, S Cherukupalli, M Xie… - Journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Currently, HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) are a major
component of the highly active anti-retroviral therapy (HAART) regimen. However, the …

Contemporary Medicinal Chemistry Strategies for the Discovery and Development of Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors.

Z Wang, S Cherukupalli, M Xie, W Wang… - Journal of Medicinal …, 2022 - europepmc.org
Currently, HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) are a major
component of the highly active anti-retroviral therapy (HAART) regimen. However, the …